237 related articles for article (PubMed ID: 28632747)
1. Selective cyclooxygenase inhibition by SC-560 improves hepatopulmonary syndrome in cirrhotic rats.
Chang CC; Lee WS; Hsieh HG; Chuang CL; Huang HC; Lee FY; Lee SD
PLoS One; 2017; 12(6):e0179809. PubMed ID: 28632747
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung.
Chang CC; Wang SS; Hsieh HG; Lee WS; Chuang CL; Lin HC; Lee FY; Lee SD; Huang HC
Clin Sci (Lond); 2015 Sep; 129(6):449-60. PubMed ID: 25940601
[TBL] [Abstract][Full Text] [Related]
3. A high-dose rapamycin treatment alleviates hepatopulmonary syndrome in cirrhotic rats.
Chang CC; Chuang CL; Hsin IF; Hsu SJ; Huang HC; Lee FY; Lee SD
J Chin Med Assoc; 2020 Jan; 83(1):32-40. PubMed ID: 31567652
[TBL] [Abstract][Full Text] [Related]
4. Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats.
Chang CC; Chuang CL; Tsai MH; Hsin IF; Hsu SJ; Huang HC; Lee FY; Lee SD
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925782
[TBL] [Abstract][Full Text] [Related]
5. The effects of pioglitazone in cirrhotic rats with hepatopulmonary syndrome.
Cheng TY; Lee WS; Huang HC; Lee FY; Chang CC; Lin HC; Lee SD
J Chin Med Assoc; 2017 Nov; 80(11):683-689. PubMed ID: 28969989
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis.
Chang CC; Chuang CL; Lee FY; Wang SS; Lin HC; Huang HC; Teng TH; Hsu SJ; Hsieh HG; Lee SD
Clin Sci (Lond); 2013 Apr; 124(7):457-66. PubMed ID: 23043394
[TBL] [Abstract][Full Text] [Related]
7. TNF-α neutralization improves experimental hepatopulmonary syndrome in rats.
Liu L; Liu N; Zhao Z; Liu J; Feng Y; Jiang H; Han D
Liver Int; 2012 Jul; 32(6):1018-26. PubMed ID: 22672643
[TBL] [Abstract][Full Text] [Related]
8. Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats.
Ko MT; Huang HC; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Lee FY; Chang CC; Lee SD
J Chin Med Assoc; 2017 Aug; 80(8):467-475. PubMed ID: 28676445
[TBL] [Abstract][Full Text] [Related]
9. Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in mice.
Raevens S; Geerts A; Paridaens A; Lefere S; Verhelst X; Hoorens A; Van Dorpe J; Maes T; Bracke KR; Casteleyn C; Jonckx B; Horvatits T; Fuhrmann V; Van Vlierberghe H; Van Steenkiste C; Devisscher L; Colle I
Hepatology; 2018 Aug; 68(2):634-651. PubMed ID: 29023811
[TBL] [Abstract][Full Text] [Related]
10. The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.
Zhang J; Yang W; Luo B; Hu B; Maheshwari A; Fallon MB
J Hepatol; 2012 Oct; 57(4):752-8. PubMed ID: 22659346
[TBL] [Abstract][Full Text] [Related]
11. Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod.
Baweja S; Kumari A; Negi P; Tomar A; Tripathi DM; Mourya AK; Rastogi A; Subudhi PD; Thangariyal S; Kumar G; Kumar J; Reddy GS; Sood AK; Vashistha C; Sarohi V; Bihari C; Maiwall R; Sarin SK
J Hepatol; 2023 Jul; 79(1):167-180. PubMed ID: 36996943
[TBL] [Abstract][Full Text] [Related]
12. Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
Li X; Chen Y; Wang L; Shang G; Zhang C; Zhao Z; Zhang H; Liu A
Braz J Med Biol Res; 2016 Jul; 49(7):. PubMed ID: 27383124
[TBL] [Abstract][Full Text] [Related]
13. The role of receptor tyrosine kinase activation in cholangiocytes and pulmonary vascular endothelium in experimental hepatopulmonary syndrome.
Yang W; Zhang J; Hu B; Wu W; Venter J; Alpini G; Fallon MB
Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(1):G72-80. PubMed ID: 24200956
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis.
Li TH; Lee PC; Lee KC; Hsieh YC; Tsai CY; Yang YY; Huang SF; Tsai TH; Hsieh SL; Hou MC; Lin HC; Lee SD
Sci Rep; 2016 Dec; 6():39405. PubMed ID: 28009008
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 promotes pulmonary intravascular macrophage accumulation by exacerbating BMP signaling in rat experimental hepatopulmonary syndrome.
Liu C; Gao J; Chen B; Chen L; Belguise K; Yu W; Lu K; Wang X; Yi B
Biochem Pharmacol; 2017 Aug; 138():205-215. PubMed ID: 28642034
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis.
Gao JH; Wen SL; Yang WJ; Lu YY; Tong H; Huang ZY; Liu ZX; Tang CW
PLoS One; 2013; 8(7):e69309. PubMed ID: 23922700
[TBL] [Abstract][Full Text] [Related]
17. Caspase-3 inhibition prevents the development of hepatopulmonary syndrome in common bile duct ligation rats by alleviating pulmonary injury.
Chen B; Ning JL; Gu JT; Cui J; Yang Y; Wang Z; Zeng J; Yi B; Lu KZ
Liver Int; 2015 Apr; 35(4):1373-82. PubMed ID: 25113058
[TBL] [Abstract][Full Text] [Related]
18. Selective cyclooxygenase inhibition improves hepatic encephalopathy in fulminant hepatic failure of rat.
Chang CC; Wang SS; Huang HC; Chan CY; Lee FY; Lin HC; Nong JY; Chuang CL; Lee SD
Eur J Pharmacol; 2011 Sep; 666(1-3):226-32. PubMed ID: 21575628
[TBL] [Abstract][Full Text] [Related]
19. Tea polyphenols and Levofloxacin alleviate the lung injury of hepatopulmonary syndrome in common bile duct ligation rats through Endotoxin -TNF signaling.
Zhu J; Qiu J; Chen K; Wang W; Zheng S
Biomed Pharmacother; 2021 May; 137():111263. PubMed ID: 33516071
[TBL] [Abstract][Full Text] [Related]
20. CXCR2 is involved in pulmonary intravascular macrophage accumulation and angiogenesis in a rat model of hepatopulmonary syndrome.
Li X; Chen Y; Chang Y; Li S; Zhao Z; Zhang H
Clin Sci (Lond); 2017 Jan; 131(2):159-168. PubMed ID: 27879294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
